Relevance of interleukin-10RB to chronic hepatitis B virus infection and biological activities of interferon-λ and interleukin-22

Hepatology International

Volumn 7, Issue 1, 2013, Pages 111-118

  Cho, Okki ^a   Cheong, Jae Youn ^a   Jun, Ka Jung ^a   Kim, Soon Sun ^a   Chwae, Yong Joon ^a   Kim, Kyongmin ^a   Park, Sun ^a   Cho, Sung Won ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Chronic hepatitis B; HBV replication; IFN ; IL 10R2; IL 22; Single nucleotide polymorphism

Indexed keywords

CYTOKINE; FLUOROURACIL; GLUTAMIC ACID; INTERLEUKIN 10RB; INTERLEUKIN 22; LYSINE; PEGINTERFERON LAMBDA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASIAN; B LYMPHOCYTE; BIOLOGICAL ACTIVITY; CELL DEATH; CELL TRANSFORMATION; CELL VIABILITY; CELLULAR IMMUNITY; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; GENETIC TRANSCRIPTION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; KOREAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS CELL INTERACTION; VIRUS REPLICATION;

EID: 84875245993     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-012-9361-8     Document Type: Article

References (32)

1. RP Donnelly F Sheikh SV Kotenko H Dickensheets 2004 The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain J Leukoc Biol 76 314 321 15123776 10.1189/jlb.0204117 1:CAS:528:DC%2BD2cXmtlKrs70%3D
2. NJ Megjugorac GE Gallagher G Gallagher 2009 Modulation of human plasmacytoid DC function by IFN-lambda1 (IL-29) J Leukoc Biol 86 1359 1363 19759281 10.1189/jlb.0509347 1:CAS:528:DC%2BD1MXhsFGqsbvM
3. S Radaeva R Sun HN Pan F Hong B Gao 2004 Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation Hepatology 39 1332 1342 15122762 10.1002/hep.20184 1:CAS:528:DC%2BD2cXks1Sjtbo%3D
4. SE Doyle H Schreckhise K Khuu-Duong, et al. 2006 Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes Hepatology 44 896 906 17006906 10.1002/hep.21312 1:CAS:528:DC%2BD28XhtFyqsrzI
5. D Ma D Jiang M Qing, et al. 2009 Antiviral effect of interferon lambda against West Nile virus Antiviral Res 83 53 60 19501257 10.1016/j.antiviral. 2009.03.006 1:CAS:528:DC%2BD1MXntVGkurg%3D
6. WJ Jordan J Eskdale S Srinivas, et al. 2007 Human interferon lambda-1 (IFN-lambda1/IL-29) modulates the Th1/Th2 response Genes Immun 8 254 261 17361203 10.1038/sj.gene.6364382 1:CAS:528:DC%2BD2sXksFeltrs%3D
7. SG Maher F Sheikh AJ Scarzello, et al. 2008 IFNalpha and IFNlambda differ in their antiproliferative effects and duration of JAK/STAT signaling activity Cancer Biol Ther 7 1109 1115 18698163 10.4161/cbt.7.7.6192 1:CAS:528: DC%2BD1cXhtFWhs7nJ
8. FV Chisari C Ferrari 1995 Hepatitis B virus immunopathogenesis Ann Rev Immunol 13 29 60 10.1146/annurev.iy.13.040195.000333 1:CAS:528: DyaK2MXltFamtLY%3D
9. LG Guidotti FV Chisari 2006 Immunobiology and pathogenesis of viral hepatitis Annu Rev Pathol 1 23 61 18039107 10.1146/annurev.pathol.1.110304. 100230 1:CAS:528:DC%2BD28XktVOitb4%3D
10. AJ Frodsham L Zhang U Dumpis, et al. 2006 Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence Proc Natl Acad Sci USA 103 9148 9153 16757563 10.1073/pnas.0602800103 1:CAS:528:DC%2BD28XmsVWjsb0%3D
11. DQ Chen Y Zeng J Zhou, et al. 2010 Association of candidate susceptible loci with chronic infection with hepatitis B virus in a Chinese population J Med Virol 82 371 378 20087947 10.1002/jmv.21716 1:CAS:528:DC%2BC3cXitlKntrc%3D
12. QM Gong XF Kong ZT Yang, et al. 2009 Association study of IFNAR2 and IL10RB genes with the susceptibility and interferon response in HBV infection J Viral Hepat 16 674 680 19714778 10.1111/j.1365-2893.2009.01130.x
13. HY Kim GS Park EG Kim, et al. 2004 Oligomer synthesis by priming deficient polymerase in hepatitis B virus core particle Virology 322 22 30 15063113 10.1016/j.virol.2004.01.009 1:CAS:528:DC%2BD2cXivVCqs7k%3D
14. RW Chen H Piiparinen M Seppanen P Koskela S Sarna M Lappalainen 2001 Real-time PCR for detection and quantitation of hepatitis B virus DNA J Med Virol 65 250 256 11536230 10.1002/jmv.2027 1:CAS:528:DC%2BD3MXntVKnsrs%3D
15. SH Hong O Cho K Kim HJ Shin SV Kotenko S Park 2007 Effect of interferon-lambda on replication of hepatitis B virus in human hepatoma cells Virus Res 126 245 249 17451832 10.1016/j.virusres.2007.03.006 1:CAS:528:DC%2BD2sXlsFGrurg%3D
16. K Hikami Y Ehara M Hasegawa, et al. 2008 Association of IL-10 receptor 2 (IL10RB) SNP with systemic sclerosis Biochem Biophys Res Commun 373 403 407 18588853 10.1016/j.bbrc.2008.06.054 1:CAS:528:DC%2BD1cXoslGmuro%3D
17. L Dumoutier A Tounsi T Michiels C Sommereyns SV Kotenko JC Renauld 2004 Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling J Biol Chem 279 32269 32274 15166220 10.1074/jbc. M404789200 1:CAS:528:DC%2BD2cXmtVChs7w%3D
18. NE Pagliaccetti EN Chu CR Bolen SH Kleinstein MD Robek 2010 Lambda and alpha interferons inhibit hepatitis B virus replication through a common molecular mechanism but with different in vivo activities Virology 401 197 206 20303135 10.1016/j.virol.2010.02.022 1:CAS:528:DC%2BC3cXlsFajtbo%3D
19. TM Kuo CP Hu YL Chen, et al. 2009 HBV replication is significantly reduced by IL-6 J Biomed Sci 16 16 41 10.1186/1423-0127-16-16
20. M Hosel M Quasdorff K Wiegmann, et al. 2009 Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection Hepatology 50 1773 1782 19937696 10.1002/hep.23226
21. W Zhang Y Chen H Wei, et al. 2008 Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts Clin Cancer Res 14 6432 6439 18927282 10.1158/1078-0432.CCR-07-4401 1:CAS:528:DC%2BD1cXht1KgtbvL
22. JD Bard P Gelebart M Anand HM Amin R Lai 2008 Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK+ anaplastic large cell lymphoma Leukemia 22 1595 1603 18509351 10.1038/leu.2008.129 1:CAS:528:DC%2BD1cXpslSnuro%3D
23. O Barca P Devesa-Peleteiro M Seoane RM Senaris VM Arce 2010 Bimodal effect of interferon-beta on astrocyte proliferation and survival: importance of nuclear factor-kappaB J Neuroimmunol 226 73 80 20576297 10.1016/j.jneuroim. 2010.05.036 1:CAS:528:DC%2BC3cXhtFGjtrnK
24. M Ferlin-Bezombes M Jourdan J Liautard J Brochier JF Rossi B Klein 1998 IFN-alpha is a survival factor for human myeloma cells and reduces dexamethasone-induced apoptosis J Immunol 161 2692 2699 9743325 1:CAS:528:DyaK1cXmtVGnu78%3D
25. Q Chen B Gong AS Mahmoud-Ahmed A Zhou ED Hsi M Hussein A Almasan 2001 Apo2L/TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma Blood 98 2183 2192 11568006 10.1182/blood.V98.7. 2183 1:CAS:528:DC%2BD3MXnsVChtrY%3D
26. P Liu M Oken B Van Ness 1999 Interferon-alpha protects myeloma cell lines from dexamethasone-induced apoptosis Leukemia 13 473 480 10086739 10.1038/sj.leu.2401334 1:CAS:528:DyaK1MXitFamtrk%3D
27. V Cheriyath KB Glaser JF Waring R Baz MA Hussein EC Borden 2007 G1P3, an IFN-induced survival factor, antagonizes TRAIL-induced apoptosis in human myeloma cells J Clin Invest 117 3107 3117 17823654 10.1172/JCI31122 1:CAS:528:DC%2BD2sXhtFCnt7jI
28. H Potu A Sgorbissa C Brancolini 2010 Identification of USP18 as an important regulator of the susceptibility to IFN-alpha and drug-induced apoptosis Cancer Res 70 655 665 20068173 10.1158/0008-5472.CAN-09-1942 1:CAS:528:DC%2BC3cXltlWqtw%3D%3D
29. Q Li K Kawamura G Ma, et al. 2010 Interferon-lambda induces G1 phase arrest or apoptosis in oesophageal carcinoma cells and produces anti-tumour effects in combination with anti-cancer agents Eur J Cancer 46 180 190 19879751 10.1016/j.ejca.2009.10.002 1:CAS:528:DC%2BD1MXhsFGrsbvN
30. MH Xie S Aggarwal WH Ho, et al. 2000 Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R J Biol Chem 275 31335 31339 10875937 10.1074/jbc.M005304200 1:CAS:528:DC%2BD3cXntlCitrs%3D
31. SV Kotenko G Gallagher VV Baurin 2003 IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex Nat Immunol 4 69 77 12483210 10.1038/ni875 1:CAS:528:DC%2BD38Xps1eltL8%3D
32. L Dumoutier C de Meester J Tavernier JC Renauld 2009 New activation modus of STAT3: a tyrosine-less region of the interleukin-22 receptor recruits STAT3 by interacting with its coiled-coil domain J Biol Chem 284 26377 26384 19632985 10.1074/jbc.M109.007955 1:CAS:528:DC%2BD1MXhtFCgs7zI